Open access · CC-BY
via OpenAlex
Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
Yifei Wang, Bin Huang, Tao Jin, Dickson Kofi Wiredu Ocansey, Jiajia Jiang, Fei Mao
Frontiers in Immunology · 2022 · ▲ 107 citations
Abstract
Intestinal fibrosis is an important complication of inflammatory bowel disease (IBD). In the course of the development of fibrosis, certain parts of the intestine become narrowed, significantly destroying the structure and function of the intestine and affecting the quality of life of patients. Chronic inflammation is an important initiating factor of fibrosis. Unfortunately, the existing anti-inflammatory drugs cannot effectively prevent and alleviate fibrosis, and there is no effective anti-fibrotic drug, which makes surgical treatment the mainstream treatment for intestinal fibrosis and stenosis. Mesenchymal stem cells (MSCs) are capable of tissue regeneration and repair through their self-differentiation, secretion of cytokines, and secretion of extracellular vesicles. MSCs have been shown to play an important therapeutic role in the fibrosis of many organs. However, the role of MSC in intestinal fibrosis largely remained unexplored. This review summarizes the mechanism of intestinal fibrosis, including the role of immune cells, TGF-β, and the gut microbiome and metabolites. Available treatment options for fibrosis, particularly, MSCs are also discussed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fimmu.2022.835005
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Wang, Y., Huang, B., Jin, T., Ocansey, D.K.W., Jiang, J., & Mao, F. (2022). Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy. <em>Frontiers in Immunology</em>. https://doi.org/10.3389/fimmu.2022.835005
Vancouver
Wang Y, Huang B, Jin T, Ocansey DKW, Jiang J, Mao F. Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy. Frontiers in Immunology. 2022. doi:10.3389/fimmu.2022.835005.
BibTeX
@article{yifei2022Intest,
title = {Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy},
author = {Yifei Wang and Bin Huang and Tao Jin and Dickson Kofi Wiredu Ocansey and Jiajia Jiang and Fei Mao},
journal = {Frontiers in Immunology},
year = {2022},
doi = {10.3389/fimmu.2022.835005},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Crohn s and Colitis 2023
Open access · CC-BY
Matrix metalloproteinases in intestinal fibrosis
World Journal of Gastroenterology 2015
Open access · CC-BY
Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives
World Journal of Stem Cells 2014
Open access · CC-BY
Mesenchymal stem cells for treatment of aortic aneurysms
Stem Cell Discovery 2018
Open access · CC-BY
Therapeutics of Stem Cell Treatment in Anti-Aging and Rejuvenation
Stem Cells and Cloning Advances and Applications 2015
Open access · CC-BY
Mesenchymal stem cell therapy for osteoarthritis: current perspectives
Current Molecular Biology Reports 2020
Preprint · OA